The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation

Abstract

frail older inpatients with AF are significantly less likely to receive warfarin than non-frail and appear more vulnerable to adverse clinical outcomes, with and without antithrombotic therapy.